ALX Oncology Holdings Inc.
ALXO Healthcare Biotechnology
In the quarter to June 2026, EPS grew 73.5%, free cash flow grew 31.7% and total debt fell 3.34%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow ALXO
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
8.26 | 9.02 | 434.22 | 363.67 | 266.21 | 182.74 | 127.76 | 44.79 |
Receivables |
0.93 | 0.54 | — | — | — | — | — | — |
Total current assets |
10.21 | 9.81 | 435.99 | 367.02 | 270.97 | 188.66 | 134.35 | 50.73 |
Property, Plant, Equpment (Net) |
0.96 | 0.86 | 0.05 | 0.90 | 3.89 | 3.59 | 2.91 | 1.20 |
Long-Term Investments |
— | — | — | — | 16.70 | 35.41 | 3.52 | 3.49 |
Goodwill and Intangible Assets (Total) |
0.00 | — | — | — | — | — | — | — |
Long-term assets (Other) |
— | 0.01 | 0.01 | 12.27 | 14.93 | 14.89 | 6.99 | 3.63 |
Total non-current assets |
— | 0.87 | 0.06 | 13.16 | 35.52 | 53.89 | 13.42 | 8.32 |
Total Assets |
— | 10.68 | 436.05 | 380.18 | 306.49 | 242.55 | 147.78 | 59.05 |
Accounts Payable |
0.70 | 3.75 | 0.00 | 3.76 | 8.07 | 8.59 | 4.50 | 4.91 |
Accrued Expenses |
— | 1.24 | 6.13 | 9.90 | 18.60 | 26.87 | 13.42 | 14.42 |
Current Part of Debt |
— | — | — | 0.74 | 1.04 | — | 0.44 | 5.22 |
Current Part of Capital Lease |
0.00 | — | — | — | — | — | — | — |
Current Part of Taxes to Pay |
0.00 | — | — | — | — | — | — | — |
Total current liabilities |
1.87 | 4.98 | 6.20 | 15.30 | 28.33 | 36.00 | 18.50 | 24.55 |
Long Term Debt (Total) |
— | 5.42 | — | 1.84 | 9.39 | 9.64 | 9.47 | 4.53 |
Non-current Revenue (Deferred) |
0.00 | — | — | — | — | — | — | — |
Liabilities (Preferred Stock) |
— | 70.36 | — | — | — | — | — | — |
Minority Interests |
0.00 | — | — | — | — | — | — | — |
Non-current Liabilities (Other) |
0.14 | 0.55 | 0.01 | 1.84 | 5.31 | 7.20 | 6.19 | 3.98 |
Total non-current liabilities |
— | 76.33 | 0.01 | 1.84 | 14.70 | 16.84 | 15.66 | 8.51 |
Total liabilities |
— | 81.32 | 6.21 | 17.13 | 43.03 | 52.84 | 34.16 | 33.07 |
Additional Paid In Capital |
0.00 | 2.14 | 548.33 | 564.99 | 589.74 | 675.68 | 734.41 | 748.72 |
Preferred Stock (Total) |
0.00 | — | — | — | — | — | — | — |
Common Stock (Net) |
0.00 | 0.00 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 |
Retained Earnings |
(53.54) | (72.78) | (118.52) | (201.98) | (325.47) | (486.27) | (621.12) | (722.82) |
Treasury Stock |
0.00 | — | — | — | — | — | — | — |
Shareholders Equity (Other) |
0.00 | — | — | — | — | — | — | — |
Common Equity (Total) |
(51.78) | (70.64) | 429.85 | 363.05 | 263.46 | 189.71 | 113.62 | 25.98 |
Shareholders Equity (Total) |
— | (70.64) | 429.85 | 363.05 | 263.46 | 189.71 | 113.62 | 25.98 |
Shareholders Equity and Liabilities (Total) |
— | 10.68 | 436.05 | 380.18 | 306.49 | 242.55 | 147.78 | 59.05 |
Shares (Common) |
— | 3.17 | 39.85 | 40.59 | 40.86 | 49.95 | 53.05 | 54.39 |
Shareholders Equity (Tangible) |
— | (70.64) | 429.85 | 363.05 | 263.46 | 189.71 | 113.62 | 25.98 |
Net Debt |
(8.26) | (3.60) | (434.22) | (361.09) | (255.78) | (173.10) | (117.85) | (35.04) |
Total Debt |
— | 5.42 | — | 2.58 | 10.43 | 9.64 | 9.90 | 9.75 |